Chemo Pharma Laboratories Ltd
Chemo Pharma Laboratories Ltd (CHEMOPH) last traded at ₹88.7, a market capitalisation of ₹13.3 crore. Over the past 52 weeks the stock has ranged between ₹72 and ₹153. Chemo Pharma Laboratories Ltd last reported results for the quarter ended Jun 2026, with sales of ₹0.07 crore and net profit of ₹0.02 crore. Figures are as of 25 Aug 2026 and are not real time.
Chemo Pharma Laboratories Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Chemo Pharma Laboratories Ltd quarterly results
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0.53 | 0 | 0 | 0.07 |
| Expenses | 0.02 | 0.02 | 0.02 | 11.83 | 0.43 | 0.09 | 0.07 | 0.05 |
| Operating profit | -0.02 | -0.02 | -0.02 | -11.83 | 0.1 | -0.09 | -0.07 | 0.02 |
| OPM % | — | — | — | — | 18.87% | — | — | 28.57% |
| Other income | 0.63 | -0.15 | -0.16 | 0.02 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.61 | -0.17 | -0.18 | -11.81 | 0.1 | -0.09 | -0.07 | 0.02 |
| Tax % | 0.00% | 0.00% | 88.89% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net profit | 0.61 | -0.17 | -0.34 | -11.81 | 0.1 | -0.09 | -0.07 | 0.02 |
| EPS (₹) | 4.07 | -1.13 | -2.27 | -78.73 | 0.67 | -0.60 | -0.47 | 0.13 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Chemo Pharma Laboratories Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0.53 | 0.6 |
| Operating profit | -0.34 | -0.41 | -0.2 | -0.19 | -0.12 | -11.87 | -0.04 |
| OPM % | — | — | — | — | — | -2,239.62% | -6.67% |
| Net profit | 0.25 | 0.56 | 0.05 | 1.2 | 0.34 | -11.85 | -0.04 |
| EPS (₹) | 1.67 | 3.73 | 0.33 | 8.00 | 2.27 | -79.00 | -0.27 |
TTM is the trailing twelve months to the most recent quarter.
Chemo Pharma Laboratories Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 100%
- 10 Years
- 17%
- 5 Years
- 31%
- 3 Years
- 36%
- 1 Year
- -28%
- 10 Years
- -8%
- 5 Years
- -18%
- 3 Years
- -32%
- Last Year
- -164%
Chemo Pharma Laboratories Ltd shareholding pattern
Promoters held 27.89% at Jun 2026, broadly unchanged since Jun 2025. DIIs 0.37%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 27.88% | 27.88% | 27.88% | 27.88% | 27.89% | 27.89% | 27.89% | 27.89% |
| DIIs | 0.17% | 0.37% | 0.37% | 0.17% | 0.17% | 0.37% | 0.37% | 0.37% |
| Government | 0.00% | 0.00% | 0.00% | 0.20% | 0.20% | 0.00% | 0.00% | 0.00% |
| Public | 71.95% | 71.75% | 71.75% | 71.74% | 71.75% | 71.74% | 71.76% | 71.75% |
| No. of shareholders | 6,382 | 6,576 | 6,510 | 6,422 | 6,409 | 6,360 | 6,292 | 6,264 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Chemo Pharma Laboratories Ltd corporate filings
- Newspaper Advertisement for Unaudited Financial Result for the Quarter ended on June 30, 2026.Company Updatelow impact
Cruxal's analysis: Starsource Multitrade Limited has submitted its unaudited financial results for the…
Read the full analysis - Outcome of Board Meeting held on August 14, 2026. Considered Un-audited financial results for the quarter ended on June 30, 2026 along with Limited Review Report thereon.Board Meetingmedium impact
Cruxal's analysis: Starsource Multitrade Limited reported a net profit of 2.10 lakh for the quarter ended…
Read the full analysis - Star Source Multi Trade Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve un-audited financial ....Board Meetinglow impact
Cruxal's analysis: Starsource Multitrade Limited has issued a formal intimation regarding a Board of…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Chemo Pharma Laboratories Ltd
Cruxal reads every Chemo Pharma Laboratories Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.